Sarah M. Kauss's most recent trade in Thorne Healthtech Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on April 4, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Thorne Healthtech Inc | Sarah M. Kauss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 30,000 | 105,874 | - | 0 | Common Stock | |
| Thorne Healthtech Inc | Sarah M. Kauss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 30,874 | 75,874 | - | 0 | Common Stock | |
| Thorne Healthtech Inc | Sarah M. Kauss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 30,000 | 45,000 | - | 0 | Common Stock | |
| Thorne Healthtech Inc | Sarah M. Kauss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 15,000 | 15,000 | - | 0 | Common Stock |